Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Pregabalin × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Seizures 1 Pinealoma 1 Pain, Intractable 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Meningioma 1 Medulloblastoma 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Bone Neoplasms 1 Astrocytoma 1

Interventions

Cyclophosphamide 17 pembrolizumab 11 Doxorubicin 10 fludarabine 7 Irinotecan 7 Blood Specimen Collection 7 Temozolomide 6 Etoposide 6 Radiotherapy 5 Ifosfamide 5 Gemcitabine 5 Carboplatin 5 Albumin-Bound Paclitaxel 5 Vincristine 4 Trabectedin 4 Paclitaxel 4 Dexamethasone 4 tecogalan 3 pazopanib 3 olaparib 3 nilotinib 3 dostarlimab 3 cemiplimab 3 aflibercept 3 Therapeutics 3 Taxes 3 Polymerase Chain Reaction 3 PM 01183 3 Nivolumab 3 Imatinib Mesylate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated

152 enrolled 14 charts

Bone Neoplasms, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡